Swiss Sacroma Network | Switzerland
Author Profile
Orcid ID
Bruno Fuchs, MD, PhD 🌟
Position: Professor and Chair, Sarcoma Center & Swiss Sarcoma Network
Location: Faculty of Health Science & Medicine, University of Lucerne, and LUKS University Hospital, Luzern, Switzerland
Contact: fuchs@sarcoma.surgery
Educational Background 🎓
- 2022: Guest-Professor, Medical Faculty, University of Lucerne
- 2010: Extraordinarius, Medical Faculty, University of Zurich
- 2005: Associate Professor, Medical Faculty, University of Zurich
- 2004: PhD in Biomedical Sciences (Tumor Biology), Mayo Graduate School, Mayo College of Medicine, Rochester, MN, USA
- 1996 - 2004: Training and Fellowship in Orthopedic Surgery and Musculoskeletal Oncology at Mayo Clinic, Rochester, MN, USA, and Swiss institutions
- 1992: MD, Medical Faculty, University of Zurich, Switzerland
Clinical and Research Expertise 🔬
- Specializes in the surgical treatment of bone and soft tissue tumors in both pediatric and adult patients
- Focuses on outcome analysis and quality indicators in sarcoma care
- Engages in predictive outcome analytics for improving sarcoma treatment
Academic Contributions 📚
- Authored over 200 publications and book chapters
- Acquired over 10 million Swiss Francs in research funding
- Active as a reviewer for prestigious journals and grant committees
Contributions and Research Focus on Sarcoma🏆
Fuchs has made profound contributions to the surgical treatment of bone and soft tissue tumors in both pediatric and adult patients. His research is heavily focused on the outcome analysis of sarcoma patients, defining and assessing quality indicators of sarcoma care, and predictive outcome analytics. His work is vital in improving the standards and methodologies employed in sarcoma care, directly impacting patient outcomes and care quality.
Public and Professional Service 🌐
- Founder & Chair of the Swiss Sarcoma Network
- Founder of the Sarcoma Academy
- Member of multiple medical societies including SwissOrthopaedics, FMH, and CTOS
Dr. Bruno Fuchs is recognized internationally for his extensive contributions to the field of sarcoma research and treatment. His work continues to shape the future of musculoskeletal oncology.
Notable Publications📑
"Real-World-Time Data and RCT Synergy: Advancing Personalized Medicine and Sarcoma Care through Digital Innovation"
- Authors: Philip Heesen, Georg Schelling, Mirko Birbaumer, Ruben Jäger, Beata Bode, Gabriela Studer, Bruno Fuchs
- Journal: Cancers
- Year: 2024
"Improving Sarcoma Outcomes: Target Trial Emulation to Compare the Impact of Unplanned and Planned Resections on the Outcome"
- Authors: Timothy T. A. F. Obergfell, Kim N. Nydegger, Philip Heesen, Georg Schelling, Beata Bode-Lesniewska, Gabriela Studer, Bruno Fuchs
- Journal: Cancers
- Year: 2024
"Impact of Institutional Practices and Surgical Complexity on Sarcoma Surgery Costs: Driving Efficiency in Value-Based Healthcare"
- Authors: Georg Schelling, Philip Heesen, Boris Malte Tautermann, Markus Wepf, Barbara Di Federico, Annika Frei, Kim van Oudenaarde, Pietro Giovanoli, Beata Bode-Lesniewska, Gabriela Studer et al.
- Journal: Cancers
- Year: 2024
"Development and Validation of the Bone Tumor Surgery Complexity Score"
- Authors: Annika Frei, Georg Schelling, Philip Heesen, Pietro Giovanoli, Bruno Fuchs
- Journal: Reports
- Year: 2024
"Exploring Risk Factors for Predicting 30-Day Postoperative Morbidity in Musculoskeletal Tumor Surgery"
- Authors: Philip Heesen, Maria Elyes, Jan Domanski, Georg Schelling, Sören Könneker, Bruno Fuchs
- Journal: Journal of Clinical Medicine
- Year: 2024